Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Pasqualone Frank, Vice-Président. Insider active across 2 companies, notably Theravance Biopharma, Inc.. In total, 6 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €2k. History available since 20 May 2021. The latest transaction was disclosed on 23 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Frank Pasqualone is the Senior Vice President and Chief Business Officer at Theravance Biopharma, Inc. He is responsible for commercial strategy and business development. His expertise contributes to the growth and innovation of the company.